Search tool

Molecular structure of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV).

Molecular structure of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV).

Molecular structure of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine).

Robert West (University College London) on the definition of addiction and the EMCDDA Insights publication on 'Models of addiction'.

Leading European and international experts will meet in Lisbon from 27-28 June for the Third international multidisciplinary forum on new drugs, jointly organised by the EMCDDA and Europol. Significant developments in this...

Several thousands of cocaine-related emergencies are reported in Europe every year, representing a considerable burden on services. The EMCDDA studies the type of cocaine-related problems reported and the potential of using hospital...

Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today. In this analysis, the EMCDDA looks...

The conference will review the 'state of the art' in this emerging discipline, providing an opportunity to present latest research findings, methodological developments and new applications. This multidisciplinary event will bring together...

Molecular structure of 1-(1H-indol-5-yl)propan-2-amine (5-IT).